Biotech · Private company
Mycovia Pharmaceuticals Inc.
Track this companyFree. Adds Mycovia Pharmaceuticals Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- Fluconazole 150mg capsulePhase 3 · Recurrent Vulvovaginal CandidiasisClinicalTrials.gov · fetched Nov 12, 2026
- Oteseconazole (VT-1161)Phase 3 · Recurrent Vulvovaginal CandidiasisClinicalTrials.gov · fetched Nov 12, 2026
- Oteseconazole (VT-1161) 150mg capsulePhase 3 · Recurrent Vulvovaginal CandidiasisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Study of Oral Oteseconazole (VT-1161) for Acute Yeast Infections in Patients With Recurrent Yeast InfectionsPHASE3 · COMPLETED · started Mar 13, 2019ClinicalTrials.gov NCT03840616 · fetched Nov 12, 2026
- A Study of Oral Oteseconazole (VT-1161) for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)PHASE3 · COMPLETED · started Aug 23, 2018ClinicalTrials.gov NCT03561701 · fetched Nov 12, 2026
- A Study of Oral Oteseconazole for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)PHASE3 · COMPLETED · started Aug 16, 2018ClinicalTrials.gov NCT03562156 · fetched Nov 12, 2026